Titulo:
Response to vismodegib in recurrent meduloblastoma.
.
Guardado en:
2256-2877
2256-2915
2
2013-10-01
45
51
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
info:eu-repo/semantics/openAccess
http://purl.org/coar/access_right/c_abf2
| id |
metarevistapublica_acho_revistacolombianadehematologiayoncologia_27_article_353 |
|---|---|
| record_format |
ojs |
| spelling |
Response to vismodegib in recurrent meduloblastoma. Respuesta a vismodegib en un meduloblastoma recurrente. . Bernal, Laura Useche, Nicolás Bermúdez, Sonia Cardona, Andrés Felipe 2 3 Núm. 3 , Año 2013 : Octubre Artículo de revista Journal article 2013-10-01T00:00:00Z 2013-10-01T00:00:00Z 2013-10-01 application/pdf Asociación Colombiana de Hematología y Oncología (ACHO) Revista Colombiana de Hematología y Oncología 2256-2877 2256-2915 https://revista.acho.info/index.php/acho/article/view/353 10.51643/22562915.353 https://doi.org/10.51643/22562915.353 eng https://creativecommons.org/licenses/by-nc-sa/4.0 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. 45 51 Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol. 2012;14 Suppl 5:v1-49. Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med. 2009;361(12):1173-8. Shonka N, Brandes A, De Groot JF. Adult medulloblastoma, from spongioblastoma cerebelli to the present day: a review of treatment and the integration of molecular markers. Oncology (Williston Park). 2012;26(11):1083-91. Atwood SX, Chang AL, Oro AE. Hedgehog pathway inhibition and the race against tumor evolution. J Cell Biol. 2012;199(2):193-7. Watson S, Serrate C, Vignot S. Voie de signalisation Sonic Hedgehog : du développement embryonnaire aux thérapies moléculaires ciblées. Bulletin du Cancer. 2010;97(12):1477-83. Ruch JM, Kim EJ. Hedgehog signaling pathway and cancer therapeutics: progress to date. Drugs. 2013;73(7):613-23. Chen JK, Taipale J, Cooper MK, Beachy PA. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 2002;16(21):2743-8. LoRusso PM, Rudin CM, Reddy JC, Tibes R, Weiss GJ, Borad MJ, et al. Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res. 2011;17(8):2502-11. Gajjar AJ, Amar J. A prospective phase II study to determine the efficacy of GDC 0449 (vismodegib) in adults with recurrent medulloblastoma (MB): A Pediatric Brain Tumor Consortium study (PBTC 25B). J Clin Oncol. 2013; suppl: abstr 2035. Weiss GJ, Korn RL. Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors. Cancer. 2012;118(21):5310-9. https://revista.acho.info/index.php/acho/article/download/353/314 info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 http://purl.org/redcol/resource_type/ARTREF info:eu-repo/semantics/publishedVersion http://purl.org/coar/version/c_970fb48d4fbd8a85 info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 Text Publication |
| institution |
ASOCIACION COLOMBIANA DE HEMATOLOGIA Y ONCOLOGIA |
| thumbnail |
https://nuevo.metarevistas.org/ASOCIACIONCOLOMBIANADEHEMATOLOGIAYONCOLOGIA/logo.png |
| country_str |
Colombia |
| collection |
Revista Colombiana de Hematología y Oncología |
| title |
Response to vismodegib in recurrent meduloblastoma. |
| spellingShingle |
Response to vismodegib in recurrent meduloblastoma. Bernal, Laura Useche, Nicolás Bermúdez, Sonia Cardona, Andrés Felipe |
| title_short |
Response to vismodegib in recurrent meduloblastoma. |
| title_full |
Response to vismodegib in recurrent meduloblastoma. |
| title_fullStr |
Response to vismodegib in recurrent meduloblastoma. |
| title_full_unstemmed |
Response to vismodegib in recurrent meduloblastoma. |
| title_sort |
response to vismodegib in recurrent meduloblastoma. |
| title_eng |
Respuesta a vismodegib en un meduloblastoma recurrente. |
| description_eng |
.
|
| author |
Bernal, Laura Useche, Nicolás Bermúdez, Sonia Cardona, Andrés Felipe |
| author_facet |
Bernal, Laura Useche, Nicolás Bermúdez, Sonia Cardona, Andrés Felipe |
| citationvolume |
2 |
| citationissue |
3 |
| citationedition |
Núm. 3 , Año 2013 : Octubre |
| publisher |
Asociación Colombiana de Hematología y Oncología (ACHO) |
| ispartofjournal |
Revista Colombiana de Hematología y Oncología |
| source |
https://revista.acho.info/index.php/acho/article/view/353 |
| language |
eng |
| format |
Article |
| rights |
https://creativecommons.org/licenses/by-nc-sa/4.0 Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2 |
| references_eng |
Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol. 2012;14 Suppl 5:v1-49. Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med. 2009;361(12):1173-8. Shonka N, Brandes A, De Groot JF. Adult medulloblastoma, from spongioblastoma cerebelli to the present day: a review of treatment and the integration of molecular markers. Oncology (Williston Park). 2012;26(11):1083-91. Atwood SX, Chang AL, Oro AE. Hedgehog pathway inhibition and the race against tumor evolution. J Cell Biol. 2012;199(2):193-7. Watson S, Serrate C, Vignot S. Voie de signalisation Sonic Hedgehog : du développement embryonnaire aux thérapies moléculaires ciblées. Bulletin du Cancer. 2010;97(12):1477-83. Ruch JM, Kim EJ. Hedgehog signaling pathway and cancer therapeutics: progress to date. Drugs. 2013;73(7):613-23. Chen JK, Taipale J, Cooper MK, Beachy PA. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 2002;16(21):2743-8. LoRusso PM, Rudin CM, Reddy JC, Tibes R, Weiss GJ, Borad MJ, et al. Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res. 2011;17(8):2502-11. Gajjar AJ, Amar J. A prospective phase II study to determine the efficacy of GDC 0449 (vismodegib) in adults with recurrent medulloblastoma (MB): A Pediatric Brain Tumor Consortium study (PBTC 25B). J Clin Oncol. 2013; suppl: abstr 2035. Weiss GJ, Korn RL. Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors. Cancer. 2012;118(21):5310-9. |
| type_driver |
info:eu-repo/semantics/article |
| type_coar |
http://purl.org/coar/resource_type/c_6501 |
| type_version |
info:eu-repo/semantics/publishedVersion |
| type_coarversion |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| type_content |
Text |
| publishDate |
2013-10-01 |
| date_accessioned |
2013-10-01T00:00:00Z |
| date_available |
2013-10-01T00:00:00Z |
| url |
https://revista.acho.info/index.php/acho/article/view/353 |
| url_doi |
https://doi.org/10.51643/22562915.353 |
| issn |
2256-2877 |
| eissn |
2256-2915 |
| doi |
10.51643/22562915.353 |
| citationstartpage |
45 |
| citationendpage |
51 |
| url2_str_mv |
https://revista.acho.info/index.php/acho/article/download/353/314 |
| _version_ |
1811200924774825984 |